Repligen
RGEN
#2261
Rank
A$12.01 B
Marketcap
A$213.48
Share price
-0.59%
Change (1 day)
-16.98%
Change (1 year)
Categories

Market capitalization of Repligen (RGEN)

Market cap: A$12.01 Billion

As of February 2026 Repligen has a market cap of A$12.01 Billion. This makes Repligen the world's 2261th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Repligen from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026A$12.01 B-13.97%
2025A$13.96 B6.55%
2024A$13.10 B-11.03%
2023A$14.73 B6.66%
2022A$13.81 B-31.6%
2021A$20.19 B48.11%
2020A$13.63 B98.19%
2019A$6.88 B109.27%
2018A$3.28 B62.4%
2017A$2.02 B39.96%
2016A$1.44 B13.05%
2015A$1.27 B61.37%
2014A$0.79 B62.42%
2013A$0.48 B158.97%
2012A$0.18 B81.36%
2011A$0.10 B-26.88%
2010A$0.14 B1%
2009A$0.14 B-15.76%
2008A$0.16 B-28.19%
2007A$0.23 B114.81%
2006A$0.10 B-34.2%
2005A$0.16 B47.08%
2004A$0.11 B-36.41%
2003A$0.17 B19.32%
2002A$0.14 B16%
2001A$0.12 B-20.76%
2000A$0.16 B51.17%
1999A$0.10 B181.86%
1998A$37.66 M74.52%
1997A$21.58 M-9.26%
1996A$23.78 M

End of Day market cap according to different sources

On Feb 3rd, 2026 the market cap of Repligen was reported to be:

A$12.01 Billion
by Nasdaq info icon info icon
A$12.01 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$208.20 B 1,632.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$304.36 B 2,432.80%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
A$464.55 B 3,765.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$161.96 B 1,247.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A$0.18 B-98.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A$1.93 B-83.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$19.69 B 63.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$14.30 B 19.08%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$15.72 B 30.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
A$14.08 B 17.22%๐Ÿ‡บ๐Ÿ‡ธ USA